The adverse effects of leukocytosis, elevated CRP levels, and other inflammatory markers, such as IL-6, on a prognosis following stroke have been well-documented in the general stroke population40,41, and in patients after MT in particular23,42,43. The gene discussed is CRP; the disease is Stroke.